Skip to content
Precision Medicine · Regenerative Research · Patent Portfolio

Research that
transforms the clinic

MediBalans conducts clinical research with direct application in patient care. Our work on Global Constraint Rule, model-based biological age assessment and regenerative therapies is developed into clinical approaches used at the clinic today — not in ten years.

7 Patent applications
3 Research Domains
42K RNA markers (BioAge™)
Unifying Principle

Global Constraint Rule

The scientific foundation unifying MediBalans patent portfolio and clinical methodology.

Global Constraint Rule (GCR) is a systems biology principle describing how biological systems — from individual cells to entire organs — always operate under prevailing constraints. When a constraint is severe enough, the entire system reconfigures to compensate.

The clinical problem is that the visible dysfunction is rarely the primary constraint. Conventional medicine often treats the secondary compensation — and wonders why the effect is absent or recurs.

The GCR framework guides MediBalans diagnostics: we systematically search for the biological root constraint driving a condition, regardless of where it manifests clinically. This is the principle behind why the same symptom can require entirely different treatment in different patients.

Seven patent applications have so far emerged from this framework — in longevity medicine, regenerative therapies and precision nutrition.

Global Constraint Rule · Core Definition

Biological systems always adapt to their most limiting factor — not their most obvious one.

Identifying and correcting the root constraint is more effective than treating the adaptive compensations it has generated.

The same symptom can have fundamentally different biological origins
Treating compensations gives temporary effect — treating the constraint gives lasting results
Multi-omics data can show patterns that guide further evaluation, but cannot establish a root cause on their own
Protocol design must be adapted to the individual's specific constraint profile
Intellectual Property

7 patent applications in precision medicine

The patent portfolio spans longevity medicine, regenerative therapies and precision nutrition — all unified by the Global Constraint Rule principle.

Patent application 01 · Longevity
Biological Age Determination via RNA Transcriptome Analysis
Method for modelling a biological age profile by comparing gene-expression patterns with age-associated reference data. The patent description does not mean the model is clinically validated.
MediBalans BioAge™
Patent application 02 · Regenerative
Translational Gap Analysis for Proteomic Intervention
Patent-pending method for identifying the discrepancy between gene expression and protein production — the translational gap driving cellular dysfunction.
Proteomics
Patent application 03 · Precision Nutrition
Intracellular Micronutrient Mapping for Protocol Design
System for translating intracellular nutritional status (55 micronutrients) into personalised supplementation protocols via GCR ranking.
CMA · Nutrition
Patent application 04 · Immunology
Dynamic Immune Reactivity Profile for Elimination Protocols
Method for time-series measurement of immune reactivity to food antigens and translating change patterns into adaptive elimination and reintroduction protocols.
ALCAT · Immunology
Patent application 05 · Methylation
Methylation Capacity Index for Regenerative Treatment Planning
Algorithm integrating SNP profile, biomarker data and clinical anamnesis into a composite methylation capacity index with direct protocol implications.
MethylDetox · Epigenetics
Patent application 06 · Neurology
Autonomic Regulation via HRV Biofeedback and Cellular Nutrition
Combination protocol integrating HRV measurement with cellular nutritional status to optimise autonomic nerve regulation and mitochondrial function.
HRV · Mitochondria
Patent application 07 · Regenerative
Multi-Omics Convergence Model for Systems Biology Diagnosis
Framework for integrating genomics, transcriptomics, proteomics and metabolomics into a convergent biological constraint profile in accordance with GCR.
Multi-omics · GCR
Patent-pending formulation · Longevity
NMN+5™
Standard NMN raises NAD+ but depletes methyl groups — creating risk of homocysteine accumulation. NMN+5™ combines NMN with five synergistic cofactors (TMG, L-5-methylfolate, P5P, R5P, hydroxy/adenosyl-B12) to sustain methylation integrity simultaneously. NAD+ provides power. Methylation provides control. NMN+5™ provides both.
Cofactors
Trimethylglycine (TMG)
L-5-Methylfolate (B9)
Pyridoxal-5-phosphate (B6)
Riboflavin-5-phosphate (B2)
Hydroxy/Adenosyl-B12
Patent-pending formulation
Flagship

MediBalans BioAge™

A research-adjacent, multi-layer assessment that uses RNA and protein patterns to estimate a biological age profile.

MediBalans BioAge™ measures gene expression and selected protein levels in the sample. A model compares these patterns with age-associated reference data and calculates a model-based biological age estimate. It is not a direct measurement of the functional age of cells, organs or the body as a whole.

The output is an age estimate with domain patterns for integrated clinical assessment. It cannot establish root cause or treatment effect on its own and does not show how many healthy life-years may be gained.

Laboratory data are generated at a specialist RNA transcriptome analysis laboratory. Genomic sequencing is carried out through the clinic's strategic partnership with Blueprint Genetics in Helsinki. Dr Mario Anthis interprets the result alongside history, function, clinical findings and established risk markers.

Book
01
RNA Transcriptome Analysis
Gene-expression patterns compared with age-associated reference data
Transcriptomics
02
Proteomic Analysis
Selected protein levels included in the model's reference profile
Proteomics
03
Translational Gap Analysis
Proprietary comparison of the relationship between RNA and protein patterns
Patent-pending
04
GCR Ageing Profile
Domain patterns that may warrant further clinical evaluation
GCR
05
Integrated Clinical Assessment
Any action is not based on the model value alone
Interpretation
I was 48 and wanted to know how my body was actually ageing — not what my passport says. The BioAge test gave me a biological age score and a concrete plan. Three months later I had measurable improvements across every marker.
Stefan W.  ★★★★★
BioAge™ · Longevity
Verified on Reco.se →
Partnerships

Kliniska samarbeten

MediBalans collaborates with leading diagnostic laboratories to ensure our diagnostics maintain scientific excellence.

Blueprint Genetics
Clinical genomics · Helsinki, Finland
Strategic partnership for clinical genomic sequencing. Blueprint Genetics is a clinical genetic testing laboratory used by hospitals and research centres. The MediBalans product specification for whole genome sequencing is 30× deep sequencing (WGS). A genetic finding shows predisposition, not a current disease state, and is always interpreted alongside clinical data.
CLIA-certified (#99D2092375)
CAP-accredited (#9257331)
FINAS-accredited (T292) to SFS-EN ISO 15189:2022
Genova Diagnostics
Functional diagnostics · Distributor
MediBalans is the exclusive Genova Diagnostics distributor in Sweden. Genova is a world-leading provider of functional diagnostic tests in gut health, hormones, nutritional status and metabolomics.
GI Effects® Comprehensive Stool Profile
DUTCH Complete hormone panel
NutrEval® metabolomics
Cell Science Systems
Immune reactivity · Distributor
Distributor of the ALCAT test in Sweden. Cell Science Systems are the creators of ALCAT — a test for delayed immune reactivity to foods, additives and chemicals, supported by a double-blind randomised controlled trial (Ali et al., BMJ Open Gastroenterology 2017).
ALCAT: 250 foods (ALCAT 250) or 483 substances in the extended panel (ALCAT 483)
ALCAT chemicals & additives
ALCAT moulds & antibiotics
Cell Science Systems — CMA
Intracellular nutrition · CMA
Cellular Micronutrient Assay (CMA) from Cell Science Systems — an intracellular micronutrient test. Measures 55 micronutrients directly in white blood cells, showing functional cellular nutrient status rather than serum concentration.
CMA — 55 intracellular micronutrients
Antioxidant status and immune function
Applied Research

Research applied to you

Our research is not academic — it is applied directly in every patient encounter. Book a consultation to see how the GCR framework and our diagnostic portfolio can be applied to your situation.